General Information of the Compound
Compound ID
CP0070013
Compound Name
US9453017, 2
    Show/Hide
Synonyms
BDBM247410
CHEMBL3947795
SCHEMBL14833317
US9453017, 2
    Show/Hide
Structure
Formula
C25H29BrN4O2
Molecular Weight
497.437
Canonical SMILES
C[C@@H](CN1CCC(CC1)n1c2ccc(Br)cc2[nH]c1=O)NC(=O)[C@@H]1C[C@@H]1c1ccccc1
    Show/Hide
InChI
InChI=1S/C25H29BrN4O2/c1-16(27-24(31)21-14-20(21)17-5-3-2-4-6-17)15-29-11-9-19(10-12-29)30-23-8-7-18(26)13-22(23)28-25(30)32/h2-8,13,16,19-21H,9-12,14-15H2,1H3,(H,27,31)(H,28,32)/t16-,20+,21+/m0/s1
    Show/Hide
InChIKey
JSVNNLRZCJAYTQ-ZLGUVYLKSA-N
Physicochemical Property
logP
4.0374
Rotatable Bonds
6
Heavy Atom Count
32
Polar Areas
70.13
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 74763829
ChEMBL ID
CHEMBL3947795
Clinical Information about the Compound
Drug 1 ( US9453017, 2 )
Drug Name US9453017, 2
Target(s)
Phospholipase D1 (PLD1)
Inhibitor